An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

Home Healthcare Devices Market Aging Population, Chronic Disease Surge, and Technological Innovations Fuel Growth in Home Healthcare Device ...

West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

Byram Healthcare, part of the Owens & Minor family, has launched ByramConnect, a personalized digital health program for ...

Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...

Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Managing diabetes is even harder when temperatures and humidity are rising. Find out how extreme heat can negatively affect ...